510(k) Report

510(k) · Cleared

Cleared

Abuscreen Online (R) for Cocaine Metabolite, Modif

K933053510(k) TraditionalCleared Aug 30, 199396-day reviewClass II21 CFR 862.3250

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Roche Diagnostic Systems, Inc. · DIO Enzyme Immunoassay, Cocaine And Cocaine Metabolites

Cleared on Aug 30, 1993 after a 96-day review. FDA lists a 510(k) statement for it but has not posted the file, so its predicates are not known. 3 later devices descend from it.

Decided
Aug 30, 1993
Review
96 days
Class
Class II
Product code
DIO
Recalls
None
Predicates
0

3 later devices descend from it, 1 citing it directly.

Descendants, by year cleared 1998: 1 descendant cleared2002: 1 descendant cleared2006: 1 descendant cleared1990200020102020
  1. This deviceK933053 Abuscreen Online (R) for Cocaine Metabolite, ModifRoche Diagnostic Systems, Inc. · 1993
  2. Descendant · cites it directly · 2 of its ownK983697 Modification to Abuscreen Online Cocaine MetaboliteRoche Diagnostic Systems, Inc. · 1998
  3. Descendant · 2 generations on · 1 of its ownK023281 Online Dat II Cocaine IIRoche Diagnostics Corp. · 2002
  4. Descendant · 3 generations on · 0 of its ownK062929 Quest Diagnostics Urine Cocaine Metabolite EiaQuest Diagnostics, Inc. · 2006

Most influential descendants

Showing 3 of 3 · See all
  • K983697Modification to Abuscreen Online Cocaine MetaboliteRoche Diagnostic Systems, Inc. · 1998 · cites it directly2descendants
  • K023281Online Dat II Cocaine IIRoche Diagnostics Corp. · 2002 · 2 generations on1descendant
  • K062929Quest Diagnostics Urine Cocaine Metabolite EiaQuest Diagnostics, Inc. · 2006 · 3 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K933053Abuscreen Online (R) for Cocaine Metabolite, ModifRoche Diagnostic Systems, Inc.1993—
+1K983697Modification to Abuscreen Online Cocaine MetaboliteRoche Diagnostic Systems, Inc.1998—
+2K023281Online Dat II Cocaine IIRoche Diagnostics Corp.2002—
+3K062929Quest Diagnostics Urine Cocaine Metabolite EiaQuest Diagnostics, Inc.2006—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
199810
200210
200610
FIG. 1 — Lineage of K933053, 1993–2006Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DIO? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DIO device

  1. #1 K213211 Carolina Liquid Chemistries Cocaine and…score 3.1 · 2 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against?

FDA lists a 510(k) statement for it but has not posted the file, so its predicates are not known.

What descends from it? (3)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K983697Modification to Abuscreen Online Cocaine MetaboliteRoche Diagnostic Systems, Inc.19982

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K983697 (Roche Diagnostic Systems, Inc., 1998) has gone furthest, with 2 descendants of its own.

How does its category compare?

All DIO devices

DIO Enzyme Immunoassay, Cocaine And Cocaine Metabolites: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · DIO

1in 2022

2009: 12011: 52012: 52013: 22014: 22015: 22016: 32017: 32018: 12020: 12021: 12022: 1
2007high 5 (2011) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DIO

267in 2017

2011: 65 days median2012: 139 days median2016: 88 days median2017: 267 days median
2007high 267 (2017) · low 65 (2011)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · DIO

1in 2013

2013: 1
2007high 1 (2013) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · DIO

1in 2023

2011: 42014: 12015: 72016: 92017: 162018: 122019: 222022: 12023: 1
2007high 22 (2019) · low 0 (2007)2025

MAUDE reports naming product code DIO, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20091—00
20100—00
201156504
2012513900
20132—10
20142—01
20152—07
201638809
20173267016
20181—012
20190—022
20201—00
20211—00
20221—01
20230—01
20240—00
20250—00
20260—0—
Cite this page

510(k) Report. “K933053: Abuscreen Online (R) for Cocaine Metabolite, Modif.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K933053

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026